Anti-Cytochrome P450 8B1 [M15-P3B7]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 152155 |
Applications | ELISA IHC WB |
Antigen/Gene or Protein Targets | Cytochrome P450, family 8, subfamily B, polypeptide 1 (CYP8B1) |
Reactivity | Human and Rat |
Relevance | Implicated in hepatocellular carcinoma. CYP8B1 is upregulated in primary and metaststic colorectal tumours compared to normal colon mucosa. |
Host | Mouse |
Immunogen | Peptide sequence– QPSHDVRFR (amino acids 486 – 494) |
Positive Control | ELISA- Peptide immunogen; Western Blot- Human liver microsomes; IHC- Human liver |
Subclass | IgG1 kappa |
Myeloma Used | P3X63Ag8.653 |
Recommended Growing Conditions | Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine). |
Strain | Balb/c |
Notes | This antibody was applied in a poster presented at the 2015 NCRI conference: http://abstracts.ncri.org.uk/?s=oxysterol&year_published=2015 |
Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References: 2 entries
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Europe PMC ID: 27341022
Swan et al. 2016. Oncotarget. :. PMID: 27341022.
IHC WB
Add a reference
References: 2 entries
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Swan et al. 2016. Oncotarget. :. PMID: 27341022.
IHC WB
Add a reference